Similar Papers

Paper Title
Journal
Date
Author
Retrospective Comparative Analysis of 5FU + Low-Dose Folinic Acid vs. 5FU + High-Dose Folinic Acid in the Treatment of Metastatic Colorectal Cancer
J A Maroun ... R Goel
American Journal of Clinical Oncology | VOL. 20
J A Maroun, et. al.J A Maroun ... R Goel
01 Aug 1997
High and Low Dose Folinic Acid, 5-Fluorouracil Bolus and Continuous Infusion for Poor-Prognosis Patients with Advanced Colorectal Carcinoma
Nusrat Bano ... Faaiza Qazi
Asian Pacific Journal of Cancer Prevention | VOL. 13
Nusrat Bano, et. al.Nusrat Bano ... Faaiza Qazi
31 Aug 2012
Increasing doses of 5-fluorouracil and high-dose folinic acid in the treatment of metastatic colorectal cancer.
Maurizio Meregalli ... Giancarlo Martignoni
Tumori Journal | VOL. 84
Maurizio Meregalli, et. al.Maurizio Meregalli ... Giancarlo Martignoni
01 Nov 1998
Sequential high dose methotrexate, 5-fluorouracil and folinic acid does not improve response rates in advanced colorectal cancer.
M.E Heim ... H Flechtner
Onkologie | VOL. 12
M.E Heim, et. al.M.E Heim ... H Flechtner
01 Jan 1989
View more papers

More From: European Journal of Cancer

Paper Title
Journal
Date
Author
Blocking MIF secretion enhances CAR T-cell efficacy against neuroblastoma
Josephine G.M Strijker ... Judith Wienke
European Journal of Cancer | VOL. -
Josephine G.M Strijker, et. al.Josephine G.M Strijker ... Judith Wienke
01 Jan 2025
Editorial Board
-
European Journal of Cancer | VOL. 215
--
01 Jan 2025
The prognostic and clinical significance of substantial lymphovascular space invasion in early-stage endometrial carcinoma
Zhuang Li ... Aijun Yin
European Journal of Cancer | VOL. -
Zhuang Li, et. al.Zhuang Li ... Aijun Yin
01 Jan 2025
Characteristics and outcomes in patients with lenalidomide-refractory multiple myeloma treated with 1-3 prior lines of therapy: analysis of individual patient-level data from daratumumab clinical trials
Kwee Yong ... Binod Dhakal
European Journal of Cancer | VOL. 215
Kwee Yong, et. al.Kwee Yong ... Binod Dhakal
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.